Long-term evolution of a patient diagnosed of small lung cancer with extension to the central nervous system
DOI:
https://doi.org/10.23938/ASSN.0265Keywords:
Small cell lung cancer. Brain metastases. Radiotherapy. Prognosis.Abstract
Cell lung cancer is the principal cause of cancer death in men and women. We report the case of a man diagnosed with small cell lung cancer, metastatic from the outset. The disease is stable at present, forty-seven months from diagnosis, after receiving different treatment modalities.Downloads
References
1. http://www.seom.org/es/informacion-sobre-el-cancer/info-tipos-cancer/tumores-toracios/cancer-de-pulmon?start=1#content [consultado 25/06/2014]
2. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0937 [consultado 14/04/2014]
3. GONZÁLEZ-BARCALA FJ, FALAGAN JA, GARCÍA-PRIM JM, VALDES L, CARREIRA JM, PUGA A et al. Cáncer de pulmón en el área sanitaria de Pontevedra: incidencia, presentación clínica y supervivencia. An Sist Sanit Nav 2013; 36: 217-227.
https://doi.org/10.4321/S1137-66272013000200005
4. POLEDNAK AP. Lung cancer incidence trends by histologic type in areas of California vs. other areas in the surveillance, epidemiology and end results program. Cancer Epidemiol 2009; 33: 319-24.
https://doi.org/10.1016/j.canep.2009.10.007
5. CHRISTODOULOU C, SKARLOS DV. Treatment of small cell lung cancer. Semin Respir Crit Care Med 2005; 26: 333-341.
https://doi.org/10.1055/s-2005-871992
6. SU J, ZHU S, LIU Z, JING S, SHEN W, LI J. Analysis of limited-stage small cell lung cancer after chemoradiotherapy. Onkologie 2012; 35: 362-367.
https://doi.org/10.1159/000338962
7. SPIEGELMEN D, MAURER LH, WARE JH, PERRY MC, CHAHINIAN AP, COMIS R et al. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1, 521 patients. J Clin Oncol 1989; 7: 344-354.
https://doi.org/10.1200/JCO.1989.7.3.344
8. BREMNES RM, SUNDSTROM S, ASEBU U, KAASA S, HATLEVOLL R, AAMDAL S. The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5 year follow-up. Lung Cancer 2003; 39: 303-313.
https://doi.org/10.1016/S0169-5002(02)00508-1
9. OU SH, ZIOGAS A, ZELL JA. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC). The importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol 2009; 4: 37-43.
https://doi.org/10.1097/JTO.0b013e31819140fb
10. LI J, DAI CH, CHEN P, WU JN, BAO QL, QIU H et al. Survival and prognostic factors in small cell lung cancer. Med Oncol 2010; 27: 73-81.
https://doi.org/10.1007/s12032-009-9174-3
11. BUCCHERI G, FERRIGNO D. Prognostic factors of small cell lung cancer. Hematol Oncol Clin North Am 2004; 18: 445-460.
https://doi.org/10.1016/j.hoc.2003.12.011
12. PAESMANS M, SCULIER JP, LECOMTE J, THIRIAUX J, LIBERT P, SERGYSELS R et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer 2000; 89: 523-533.
https://doi.org/10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6
13. MARTÍNEZ-GARCÍA E, IRIGOYEN M, GONZÁLEZ-MORENO O, CORRALES L, TEIJEIRA A, SALVO E et al. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci 2010; 116: 467.
https://doi.org/10.1093/toxsci/kfq138
14. GASPAR LE, MCNAMARA EJ, GAY EG, PUTNAM JB, CRAWFORD J, HERBST RS et al. Small-cell lung cancer: prognostic factors and changing treatment over 15 years. Clin Lung Cancer 2012; 13: 115-122.
https://doi.org/10.1016/j.cllc.2011.05.008
15. RICO M, MARTÍNEZ E, CHICATA V, EITO C, HERNÁNDEZ B, MARTÍNEZ M et al. Chest radiotherapy after chemotherapy and PCI for small cell lung cancer extensive disease. Radiother Oncol 2012; 103: 467.
https://doi.org/10.1016/S0167-8140(12)71547-5
16. YEE D, BUTTS C, REIMAN A, JOY A, SMYLIE M, FENTON D et al. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer. Radiother Oncol 2012; 102: 234-238.
https://doi.org/10.1016/j.radonc.2011.08.042
17. KOCHER M, SOFFIETTI R, ABACIOGLU U, VILLA S, FAUCHON F, BAUMERT BG et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 Study. J Clin Oncol 2011; 29: 134-141.
https://doi.org/10.1200/JCO.2010.30.1655
18. ARISTU JJ, CIÉRVIDE R, GURIDI J, MORENO M, ARBEA L, AZCONA JD et al. Radioterapia estereotáctica. An Sist Sanit Navar 2009; 32: 61-71.
https://doi.org/10.4321/S1137-66272009000400007
19. GANS JH, RAPER DM, SHAH AH, BREGY A, HEROS D, LALLY BE et al. The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 2013; 72: 317-325.
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
